Analyst Upgrades – NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) Stock Gets Upgraded By Barclays from Underweight ➝ Equal Weight to

Analyst Ratings For NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)

Story continues below

Today, NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) stock received an upgrade by Barclays from Underweight ➝ Equal Weight with a price target of $5.00.

Some recent analyst ratings include

  • 5/21/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
  • 2/8/2018-B. Riley initiated coverage with a Neutral ➝ Neutral rating.
  • 12/11/2017-Leerink Swann Reiterated Rating of Buy.
  • 9/17/2017-Chardan Capital Reiterated Rating of Neutral.
  • 9/12/2017-Robert W. Baird Reiterated Rating of Neutral.

Recent Insider Trading Activity For NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)
NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) has insider ownership of 6.25% and institutional ownership of 80.80%.

  • On 11/20/2017 & Johnson Johnson, Major Shareholder, sold 18,367,346 with an average share price of $2.75 per share and the total transaction amounting to $50,510,201.50.
  • On 12/22/2016 Jason S Fisherman, Director, bought 10,000 with an average share price of $3.96 per share and the total transaction amounting to $39,600.00.
  • On 12/5/2016 Mary Kay Fenton, CFO, bought 2,500 with an average share price of $4.11 per share and the total transaction amounting to $10,275.00.
  • On 12/2/2016 Joel C Barrish, Insider, bought 2,500 with an average share price of $4.06 per share and the total transaction amounting to $10,150.00.
  • On 12/30/2015 David Apelian, insider, sold 10,000 with an average share price of $10.50 per share and the total transaction amounting to $105,000.00.
  • On 12/28/2015 Mary Kay Fenton, CFO, sold 43,500 with an average share price of $10.08 per share and the total transaction amounting to $438,480.00.
  • On 11/11/2015 Nicole Vitullo, Director, sold 550,000 with an average share price of $10.17 per share and the total transaction amounting to $5,593,500.00.

Recent Trading Activity for NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)
Shares of NASDAQ:ACHN – Achillion Pharmaceuticals closed the previous trading session at 3.65 down -0.05 1.35% with 3.630000114440918 shares trading hands.

An ad to help with our costs